1. Home
  2. SEV vs CYPH Comparison

SEV vs CYPH Comparison

Compare SEV & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aptera Motors Corp.

SEV

Aptera Motors Corp.

HOLD

Current Price

$2.33

Market Cap

88.4M

Sector

Industrials

ML Signal

HOLD

Logo Cypherpunk Technologies Inc.

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$1.69

Market Cap

73.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEV
CYPH
Founded
2019
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.4M
73.3M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
SEV
CYPH
Price
$2.33
$1.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
299.3K
6.0M
Earning Date
05-16-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
103.87
EPS
N/A
N/A
Revenue
N/A
$1,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17,757.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.29
$0.49
52 Week High
$11.24
$3.70

Technical Indicators

Market Signals
Indicator
SEV
CYPH
Relative Strength Index (RSI) 57.69 71.12
Support Level $2.28 $0.62
Resistance Level $2.45 N/A
Average True Range (ATR) 0.14 0.22
MACD 0.01 0.08
Stochastic Oscillator 63.33 75.47

Price Performance

Historical Comparison
SEV
CYPH

About SEV Aptera Motors Corp.

Aptera Motors Corp engages in the development, production, and distribution of energy efficient solar-powered, battery-electric vehicles. The company has designed the Aptera vehicle to provide up to an estimated 40 miles per day by collecting energy from the sun and storing it in its proprietary battery pack. The company operates as a single reportable segment focused on the development of solar electric vehicles.

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Share on Social Networks: